Predictors of underlying neuroblastoma and neurodevelopmental outcomes in children with opsoclonus-myoclonus syndrome: a retrospective cohort study in China. (PubMed, Front Neurol) - Oct 18, 2026 - "The main variables influencing the neurodevelopmental prognosis in OMS patients, ranked from highest to lowest importance, are as follows: chemotherapy, rituximab, myoclonus at onset, immunotherapy initiation, tumor, age at onset, gender, ataxia at onset, OMS severity at onset, opsoclonus at onset, and ataxia at onset...Opsoclonus as the initial symptom may be a predictive indicator for the underlying NB. With NB and chemotherapy are the key factors for the favorable neurodevelopmental prognosis of OMS patients."
Journal • Retrospective data • Ataxia • Movement Disorders • Neuroblastoma • Oncology • Solid Tumor
|
|
Penghui Wu; Qing Sun; Weihong Zhao; Yao Xie; Yuwu Jiang
|